Nasdaq · CIK 0001114995
PI IMPINJ INC
Insider trading from SEC Form 4. Last filing Mar 25, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company
Signals
Open-market buys and sells at IMPINJ INC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 48Moderate | sell 3 | Baker Cary CHIEF FINANCIAL OFFICER | $153k | 1,553 | -2% | - | |
| 63Notable | sell 3 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | $823k | 8,334 | -2% | - | |
| 43Moderate | sell 3 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | $263k | 2,666 | -4% | - | |
| 28Weak | sell 3 | Baker Cary CHIEF FINANCIAL OFFICER | $41k | 290 | -0% | - | |
| 35Weak | sell 3 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | $119k | 841 | -0% | - | |
| 22Weak | sell 3 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | $53k | 378 | -1% | - | |
| 30Weak | sell 5 | Baker Cary CHIEF FINANCIAL OFFICER | $73k | 499 | -1% | - | |
| 37Weak | sell 5 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | $220k | 1,504 | -0% | - | |
| 24Weak | sell 5 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | $85k | 580 | -1% | - | |
| 30Weak | sell 5 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | $121k | 826 | -1% | - | |
| 20Weak | sell 5 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | $31k | 210 | -3% | - | |
| 26Weak | sell 3 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | $130k | 697 | -9% | - | |
| 25Weak | sell 410b5-1 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | $2.8M | 15,000 | -21% | - | |
| 55Moderate | sell 4 | Gibson Daniel Patrick director | $2.9M | 14,476 | -1% | - | |
| 60Notable | sell 6 | Gibson Daniel Patrick director | $67M | 328,616 | -13% | - | |
| 50Moderate | sell 6 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | $5.1M | 25,180 | -7% | - | |
| 75Notable | sell 6 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | $2.3M | 11,549 | -65% | - | |
| 60Notable | sell 6 | Gibson Daniel Patrick director | $86M | 431,153 | -15% | - | |
| 55Moderate | sell 6 | Gibson Daniel Patrick director | $23M | 118,043 | -4% | - | |
| 55Moderate | sell 5 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | $7.0M | 35,000 | -11% | - | |
| 55Moderate | sell 5 | Gibson Daniel Patrick director | $35M | 175,804 | -5% | - | |
| 52Moderate | sell 6 | Baker Cary CHIEF FINANCIAL OFFICER | $3.1M | 15,000 | -17% | - | |
| 50Moderate | sell 6 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | $2.0M | 10,000 | -14% | - | |
| 31Weak | sell 4 | Baker Cary CHIEF FINANCIAL OFFICER | $87k | 366 | -1% | - | |
| 39Weak | sell 4 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | $290k | 1,219 | -0% | - | |
| 25Weak | sell 4 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | $116k | 488 | -1% | - | |
| 30Weak | sell 4 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | $102k | 427 | -1% | - |
Congressional trades
3 trades in PI disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Marjorie Taylor Greene House · R-GA | Purchase | PI Impinj, Inc. - Common Stock | $1,001 to $15k | May 14, 2025 | 5 days after the trade |
| Marjorie Taylor Greene House · R-GA | Purchase | PI Impinj, Inc. - Common Stock | $1,001 to $15k | May 5, 2025 | 1 day after the trade |
| Marjorie Taylor Greene House · R-GA | Purchase | PI Impinj, Inc. - Common Stock | $1,001 to $15k | Mar 3, 2025 | 6 days after the trade |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 23, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +782 | $0.00 | $0 | 77,233 | Mar 25, 2025 |
| Mar 23, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +2,594 | $0.00 | $0 | 356,670 | Mar 25, 2025 |
| Mar 23, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +1,224 | $0.00 | $0 | 357,894 | Mar 25, 2025 |
| Mar 23, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +479 | $0.00 | $0 | 77,712 | Mar 25, 2025 |
| Mar 23, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +7,268 | $0.00 | $0 | 365,162 | Mar 25, 2025 |
| Mar 23, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +2,386 | $0.00 | $0 | 80,098 | Mar 25, 2025 |
| Mar 24, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,436 | $90.25 | $130k | 78,662 | Mar 25, 2025 |
| Mar 24, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -4,363 | $90.25 | $394k | 360,799 | Mar 25, 2025 |
| Mar 23, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -782 | $0.00 | $0 | 3,125 | Mar 25, 2025 |
| Mar 23, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitsderivative | -2,594 | $0.00 | $0 | 10,375 | Mar 25, 2025 |
| Mar 23, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -479 | $0.00 | $0 | 3,833 | Mar 25, 2025 |
| Mar 23, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Resricted Stock Uiitsderivative | -2,386 | $0.00 | $0 | 7,159 | Mar 25, 2025 |
| Mar 23, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitsderivative | -1,224 | $0.00 | $0 | 9,790 | Mar 25, 2025 |
| Mar 23, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitsderivative | -7,268 | $0.00 | $0 | 21,807 | Mar 25, 2025 |
| Feb 20, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | AGrant or award Common Stock | +6,250 | $0.00 | $0 | 78,004 | Feb 24, 2025 |
| Feb 20, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | AGrant or award Common Stock | +20,750 | $0.00 | $0 | 362,410 | Feb 24, 2025 |
| Feb 20, 2025 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | AGrant or award Common Stock | +7,500 | $0.00 | $0 | 74,552 | Feb 24, 2025 |
| Feb 21, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -701 | $97.82 | $69k | 77,303 | Feb 24, 2025 |
| Feb 21, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -3,031 | $97.74 | $296k | 359,379 | Feb 24, 2025 |
| Feb 21, 2025 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock | -878 | $97.75 | $86k | 73,674 | Feb 24, 2025 |
| Feb 21, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -1,348 | $98.38 | $133k | 358,031 | Feb 24, 2025 |
| Feb 21, 2025 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock | -507 | $98.37 | $50k | 73,167 | Feb 24, 2025 |
| Feb 21, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -234 | $98.86 | $23k | 77,069 | Feb 24, 2025 |
| Feb 21, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -3,875 | $99.70 | $386k | 354,156 | Feb 24, 2025 |
| Feb 21, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -618 | $99.79 | $62k | 76,451 | Feb 24, 2025 |
| Feb 21, 2025 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock | -1,281 | $99.72 | $128k | 71,886 | Feb 24, 2025 |
| Feb 21, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -80 | $100.25 | $8,020 | 354,076 | Feb 24, 2025 |
| Feb 10, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +10,000 | $22.40 | $224k | 343,856 | Feb 12, 2025 |
| Feb 10, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | GGift Common Stock | -1,830 | $0.00 | $0 | 342,026 | Feb 12, 2025 |
| Feb 11, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | GGift Common Stock | -366 | $0.00 | $0 | 341,660 | Feb 12, 2025 |
| Feb 10, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Stock Option (right to buy)derivative | -10,000 | $0.00 | $0 | 30,536 | Feb 12, 2025 |
| Jan 12, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +937 | $0.00 | $0 | 72,044 | Jan 14, 2025 |
| Jan 12, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +3,125 | $0.00 | $0 | 334,697 | Jan 14, 2025 |
| Jan 12, 2025 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Common Stock | +1,250 | $0.00 | $0 | 67,430 | Jan 14, 2025 |
| Jan 13, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -140 | $140.56 | $20k | 71,904 | Jan 14, 2025 |
| Jan 13, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -371 | $140.63 | $52k | 334,326 | Jan 14, 2025 |
| Jan 13, 2025 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock | -155 | $140.63 | $22k | 67,275 | Jan 14, 2025 |
| Jan 13, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -150 | $141.33 | $21k | 71,754 | Jan 14, 2025 |
| Jan 13, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -470 | $141.33 | $66k | 333,856 | Jan 14, 2025 |
| Jan 13, 2025 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock | -223 | $141.34 | $32k | 67,052 | Jan 14, 2025 |
| Jan 12, 2025 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -937 | $0.00 | $0 | 938 | Jan 14, 2025 |
| Jan 12, 2025 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 1,250 | Jan 14, 2025 |
| Jan 12, 2025 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitsderivative | -3,125 | $0.00 | $0 | 3,125 | Jan 14, 2025 |
| Dec 23, 2024 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | MOption exercise Common Stock | +1,562 | $0.00 | $0 | 61,127 | Dec 26, 2024 |
| Dec 23, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | MOption exercise Common Stock | +413 | $0.00 | $0 | 7,189 | Dec 26, 2024 |
| Dec 23, 2024 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +781 | $0.00 | $0 | 71,127 | Dec 26, 2024 |
| Dec 23, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +2,594 | $0.00 | $0 | 331,852 | Dec 26, 2024 |
| Dec 23, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Common Stock | +937 | $0.00 | $0 | 66,231 | Dec 26, 2024 |
| Dec 23, 2024 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | MOption exercise Common Stock | +529 | $0.00 | $0 | 61,656 | Dec 26, 2024 |
| Dec 24, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | SOpen-market sale Common Stock | -37 | $145.40 | $5,380 | 7,152 | Dec 26, 2024 |
| Dec 23, 2024 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Common Stock | +479 | $0.00 | $0 | 71,606 | Dec 26, 2024 |
| Dec 23, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +1,224 | $0.00 | $0 | 333,076 | Dec 26, 2024 |
| Dec 23, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Common Stock | +529 | $0.00 | $0 | 66,760 | Dec 26, 2024 |
| Dec 24, 2024 | Baker Cary CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -499 | $146.06 | $73k | 71,107 | Dec 26, 2024 |
| Dec 24, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -1,504 | $146.22 | $220k | 331,572 | Dec 26, 2024 |
| Dec 24, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock | -575 | $146.06 | $84k | 66,185 | Dec 26, 2024 |
| Dec 24, 2024 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | SOpen-market sale Common Stock | -816 | $146.06 | $119k | 60,840 | Dec 26, 2024 |
| Dec 24, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | SOpen-market sale Common Stock | -173 | $146.20 | $25k | 6,979 | Dec 26, 2024 |
| Dec 23, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | MOption exercise Restricted Stock Unitsderivative | -413 | $0.00 | $0 | 3,719 | Dec 26, 2024 |
| Dec 24, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock | -5 | $146.73 | $734 | 66,180 | Dec 26, 2024 |
| Dec 24, 2024 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | SOpen-market sale Common Stock | -10 | $146.73 | $1,467 | 60,830 | Dec 26, 2024 |
| Dec 23, 2024 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -781 | $0.00 | $0 | 3,907 | Dec 26, 2024 |
| Dec 23, 2024 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | MOption exercise Restricted Stock Unitsderivative | -1,562 | $0.00 | $0 | 7,813 | Dec 26, 2024 |
| Dec 23, 2024 | Baker Cary CHIEF FINANCIAL OFFICER | MOption exercise Restricted Stock Unitsderivative | -479 | $0.00 | $0 | 4,312 | Dec 26, 2024 |
| Dec 23, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitsderivative | -2,594 | $0.00 | $0 | 12,969 | Dec 26, 2024 |
| Dec 23, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Restricted Stock Unitsderivative | -937 | $0.00 | $0 | 4,688 | Dec 26, 2024 |
| Dec 23, 2024 | MECKLAI HUSSEIN CHIEF OPERATING OFFICER | MOption exercise Restricted Stock Unitsderivative | -529 | $0.00 | $0 | 4,759 | Dec 26, 2024 |
| Dec 23, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Restricted Stock Unitsderivative | -1,224 | $0.00 | $0 | 11,014 | Dec 26, 2024 |
| Dec 23, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Restricted Stock Unitsderivative | -529 | $0.00 | $0 | 4,759 | Dec 26, 2024 |
| Nov 20, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | MOption exercise Common Stock | +1,375 | $0.00 | $0 | 7,473 | Nov 22, 2024 |
| Nov 21, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | SOpen-market sale Common Stock | -697 | $186.14 | $130k | 6,776 | Nov 22, 2024 |
| Nov 20, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | MOption exercise Restricted Stock Unitsderivative | -1,375 | $0.00 | $0 | 12,375 | Nov 22, 2024 |
| Nov 13, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Common Stock10b5-1 | +7,500 | $17.33 | $130k | 72,794 | Nov 14, 2024 |
| Nov 12, 2024 | Gibson Daniel Patrick director | SOpen-market sale Common Stockindirect: See Footnote | -11,926 | $198.56 | $2.4M | 2,131,810 | Nov 14, 2024 |
| Nov 13, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -1,366 | $191.88 | $262k | 71,428 | Nov 14, 2024 |
| Nov 13, 2024 | Gibson Daniel Patrick director | SOpen-market sale Common Stockindirect: See Footnote | -2,550 | $195.41 | $498k | 2,129,260 | Nov 14, 2024 |
| Nov 13, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -2,281 | $192.73 | $440k | 69,147 | Nov 14, 2024 |
| Nov 13, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -1,562 | $193.87 | $303k | 67,585 | Nov 14, 2024 |
| Nov 13, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -2,087 | $194.69 | $406k | 65,498 | Nov 14, 2024 |
| Nov 13, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -204 | $195.83 | $40k | 65,294 | Nov 14, 2024 |
| Nov 14, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Common Stock10b5-1 | +7,500 | $17.33 | $130k | 72,794 | Nov 14, 2024 |
| Nov 14, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -1,192 | $179.29 | $214k | 71,602 | Nov 14, 2024 |
| Nov 14, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -1,698 | $180.08 | $306k | 69,904 | Nov 14, 2024 |
| Nov 14, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -2,298 | $180.99 | $416k | 67,606 | Nov 14, 2024 |
| Nov 14, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -905 | $181.99 | $165k | 66,701 | Nov 14, 2024 |
| Nov 14, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -651 | $183.02 | $119k | 66,050 | Nov 14, 2024 |
| Nov 14, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | SOpen-market sale Common Stock10b5-1 | -756 | $184.55 | $140k | 65,294 | Nov 14, 2024 |
| Nov 13, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Stock Option (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 9,653 | Nov 14, 2024 |
| Nov 14, 2024 | DOSSETT JEFFREY CHIEF REVENUE OFFICER | MOption exercise Stock Option (right to buy)derivative10b5-1 | -7,500 | $0.00 | $0 | 2,153 | Nov 14, 2024 |
| Nov 8, 2024 | Gibson Daniel Patrick director | SOpen-market sale Common Stockindirect: See Footnote | -25,000 | $202.14 | $5.1M | 2,447,352 | Nov 12, 2024 |
| Nov 8, 2024 | Gibson Daniel Patrick director | SOpen-market sale Common Stockindirect: See Footnote | -225,000 | $203.10 | $46M | 2,222,352 | Nov 12, 2024 |
| Nov 11, 2024 | Gibson Daniel Patrick director | SOpen-market sale Common Stockindirect: See Footnote | -78,616 | $201.79 | $16M | 2,143,736 | Nov 12, 2024 |
| Nov 8, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | SOpen-market sale Common Stock | -7,569 | $200.28 | $1.5M | 10,078 | Nov 8, 2024 |
| Nov 6, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | MOption exercise Common Stock | +25,000 | $33.77 | $844k | 364,438 | Nov 8, 2024 |
| Nov 8, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | SOpen-market sale Common Stock | -2,968 | $201.64 | $598k | 7,110 | Nov 8, 2024 |
| Nov 6, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -1,504 | $201.54 | $303k | 362,934 | Nov 8, 2024 |
| Nov 8, 2024 | PHELAN CATHAL G CHIEF INNOVATION OFFICER | SOpen-market sale Common Stock | -1,012 | $202.36 | $205k | 6,098 | Nov 8, 2024 |
| Nov 6, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -2,786 | $202.87 | $565k | 360,148 | Nov 8, 2024 |
| Nov 6, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -3,940 | $203.81 | $803k | 356,208 | Nov 8, 2024 |
| Nov 6, 2024 | DIORIO CHRIS PH.D. CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stock | -1,241 | $204.67 | $254k | 354,967 | Nov 8, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Baker CaryCHIEF FINANCIAL OFFICER
- DIORIO CHRIS PH.D.CHIEF EXECUTIVE OFFICER
- DOSSETT JEFFREYCHIEF REVENUE OFFICER
- Gibson Daniel Patrickdirector, owner
- MECKLAI HUSSEINCHIEF OPERATING OFFICER
- PHELAN CATHAL GCHIEF INNOVATION OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.